Clinical Trial Update: Alternative Delivery of Dose Adjustment For Normal Eating (DAFNE) Trial in Patients With Type 1 Diabetes [NA]

View source ↗

Summary

An update on the DAFNE trial evaluating alternative delivery of dose adjustment for normal eating in Type 1 diabetes; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Type 1 Diabetes Mellitus | NA | Status: COMPLETED